Impact of Influenza B Lineage-level Mismatch Between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999-2012
Overview
Authors
Affiliations
Background: Influenza B virus strains in trivalent influenza vaccines are frequently mismatched to the circulating B strains, but the population-level impact of such mismatches is unknown. We assessed the impact of vaccine mismatch on the epidemiology of influenza B during 12 recent seasonal outbreaks of influenza in Finland.
Methods: We analyzed all available nationwide data on virologically confirmed influenza infections in all age groups in Finland between 1 July 1999 and 30 June 2012, with the exclusion of the pandemic season of 2009-2010. We derived data on influenza infections and the circulation of different lineages of B viruses during each season from the Infectious Diseases Register and the National Influenza Center, National Institute for Health and Welfare, Finland.
Results: A total of 34 788 cases of influenza were recorded. Influenza A accounted for 74.0% and influenza B for 26.0% of all typed viruses. Throughout the 12 seasons, we estimated that 41.7% (3750 of 8993) of all influenza B infections were caused by viruses representing the other genetic lineage than the one in the vaccine. Altogether, opposite-lineage influenza B viruses accounted for 10.8% of all influenza infections in the population, the proportion being highest (16.8%) in children aged 10-14 years and lowest (2.6%) in persons aged ≥70 years.
Conclusions: The population-level impact of lineage-level mismatch between the vaccine and circulating strains of influenza B viruses is substantial, especially among children and adolescents. The results provide strong support for the inclusion of both influenza B lineages in seasonal influenza vaccines.
Pekarek M, Madapong A, Wiggins J, Weaver E Int J Mol Sci. 2025; 26(4).
PMID: 40004004 PMC: 11855595. DOI: 10.3390/ijms26041538.
Matsuzaki Y, Sugawara K, Kidoguchi Y, Kadowaki Y, Shimotai Y, Katsushima Y Viruses. 2024; 16(6).
PMID: 38932274 PMC: 11209448. DOI: 10.3390/v16060983.
Unlocking the Power of Influenza Vaccines for Pediatric Population: A Narrative Review.
Albalawi A, Alhassun J, Almarshud R, Almejali H, Alharbi S, Shaybah A Cureus. 2024; 16(2):e55119.
PMID: 38558642 PMC: 10979318. DOI: 10.7759/cureus.55119.
Impact of sex on humoral immunity with live influenza B virus vaccines in mice.
Cardenas-Garcia S, Caceres C, Jain A, Geiger G, Mo J, Gay L NPJ Vaccines. 2024; 9(1):45.
PMID: 38409236 PMC: 10897209. DOI: 10.1038/s41541-024-00827-x.
One HA stalk topping multiple heads as a novel influenza vaccine.
Zhou P, Qiu T, Wang X, Yang X, Shi H, Zhu C Emerg Microbes Infect. 2023; 13(1):2290838.
PMID: 38044872 PMC: 10810646. DOI: 10.1080/22221751.2023.2290838.